Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study

Gastrointestinal Cancer

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study

Lancet Gastroenterol Hepatol

de Jonge L, Worthington J, van Wifferen F, Iragorri N, Peterse EFP, Lew JB, Greuter MJE, Smith HA, Feletto E, Yong JHE, Canfell K, Coupé VMH, Lansdorp-Vogelaar I, COVID-19 and Cancer Global Modelling Consortium working group 2.

doi: 10.1016/S2468-1253(21)00003-0

ColonoscopyGastrointestinal Cancer

Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study

Gut

Loveday C, Sud A, Jones ME, Broggio J, Scott S, Gronthound F, Torr B, Garrett A, Nicol DL, Jhanji S, Boyce SA, Williams M, Barry C, Riboli E, Kipps E, McFerran E, Muller DC, Lyratzopoulos G, Lawler M, Abulafi M, Houlston RS, Turnbull C

doi: 10.1136/gutjnl-2020-321650

ColonoscopyGastrointestinal Cancer

Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study

Lancet Gastroenterol Hepatol.

Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW

doi: 10.1016/S2468-1253(19)30176-1.

Gastrointestinal Cancer

The impact of COVID-19 pandemic on colorectal cancer patients: a single-center retrospective study

BMC Gastroenterol

Xu Y, Huang ZH, Zheng CZ, Li C, Zhang YQ, Guo TA, Liu FQ, Xu Y

doi: 10.1186/s12876-021-01768-8

Inflammatory Bowel Disease

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

United European Gastroenterol J.

Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A

doi: 10.1177/2050640620929133.

ColonoscopyGastrointestinal Cancer

Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-based Study

Gastroenterology.

Carr PR, Weigl K, Edelmann D, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M

doi: 10.1053/j.gastro.2020.03.016.

Gastrointestinal Cancer

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR

BMC Gastroenterol.

Hoffmann S, Crispin A, Lindoerfer D, Sroczynski G, Siebert U, Mansmann U, Consortium F

doi: 10.1186/s12876-020-01247-6.

Further Publications

The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study

Lancet Gastroenterol Hepatol

Henderson RH, French D, Maughan T, Adams R, Allemani C, Minicozzi P, Coleman MP, McFerran E, Sullivan R, Lawler M

doi: 10.1016/S2468-1253(21)00147-3

Inflammatory Bowel Disease

Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force

J Crohns Colitis

Dotan I, Panaccione R, Kaplan GG, O'Morain C, Lindsay JO, Abreu MT, IOIBD.

doi: 10.1093/ecco-jcc/jjaa147

Related content

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study

Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study

Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study

The impact of COVID-19 pandemic on colorectal cancer patients: a single-center retrospective study

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-based Study

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR

The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study

Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force